Is Sony Corporation (NYSE:SNE) Better Than Microsoft Corporation (NASDAQ:MSFT)?

Posted by Lynn Eisler September 30, 2013 0 Comment 574 views

Microsoft’s Xbox One will hit U.K shelves 7 days before Sony Corporation (NYSE:SNE)’s PS4. But the company is shrugging those 7 days off nonchalantly and saying that this is not really something that will count in the broader perspective of things or from a long-term point of view.

Fergal Gara, the company’s U.K Managing Director said that the 7 day early launch does not really give the Xbox any kind of advantage over its rival or vice versa. In effect, both these consoles are launching at the same time, said Gara. The PS4 will launch on the 29November which is 7 days prior to the Xbox launch.  However, things are different in the U.S where the PS4 will launch on 15 November, 7 days before the Microsoft console.

Another thing that Gara is downplaying is the cost advantage that the PS4 has over the Xbox One. In the U.K, the entry-level model will be sold at £80 less than the Xbox.

He said that though having a lower-priced product is an advantage, it is not the only factor that counts. What matters is value to the customers and that lies in the quality of content, at that price.

Sony Corporation (NYSE:SNE) had revealed that the PS4 had pulled in more than 1m pre-orders before September. Though Gara did not reveal the exact number of new pre-orders that had come in since then, he said that there has been a significant increase and that it is a very encouraging sign.

Friday’s trading

In Friday’s trading session, Sony Corporation (NYSE:SNE) stock dropped by 0.05%. The opening price of the shares was $21.30 which rose to an intraday high of $21.34 and dropped to a close of $21.29. Approximately 0.925 million shares were traded on Friday and the average volume of shares traded over a 30 day period was $2.06 million.

About Lynn Eisler

Lynn Eisler is a national news reporter focusing on economic issues, data analysis and the financial health of state and local governments. Lynn has been honored with the H.L. Mencken Award for Investigative Reporting, the Champion of Justice Award for reporting on the drug war, and the John Hancock Award for business reporting. Lynn was also a Knight Medical School Fellow at the University of Michigan.

View all post by Lynn Eisler Visit author's website

Write Your Comment